| Serie |
Englischer Name |
CAS-NR. |
Treatment effect |
| Macitentan Series |
Macitentan API |
441798-33-0 |
ActelionPharmaceuticalsInc( PAH) |
| 2-(4-Bromo-phenyl)-malonic acid dimethyl este |
149506-35-4 |
| 5-(4-Bromophenyl)-4,6-pyrimidinediol |
706811-25-8 |
| 5-(4-Bromophenyl)-4,6-pyrimidinediol |
147962-41-2 |
| 5-(4-Bromophenyl)-4,6-dichloropyrimidine;PyriMidine, 5-(4-broMophenyl)-4,6-dichloro- |
146533-41-7 |
| Brexpiprazole Series |
Brexpiprazole API |
913611-97-9 |
Antidepressant |
| Piperazin, 1-Benzo[b]thien-4-yl-, Hydrochlorid |
913614-18-3 |
| 7-Hydroxyquinolinone |
70500-72-0 |
| 1-BOC-PIPERAZINE |
57260-71-6 |
| (2E)-N-(3-Methoxyphenyl)-3-phenyl-2-propenamide |
127033-74-3 |
| Lurasidone Series |
Lurasidone API |
367514-87-2 |
Nervous system drugs |
| (R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane |
186204-35-3 |
| (3aR,7aR)-4′-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1′-piperaziniuM] Methanesulfonate |
186204-37-5 |
| (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione |
14805-29-9 |
| (1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID |
46022-05-3 |
| Etizolam Series |
Etizolam API |
40054-69-1 |
Antidepressant |
| 2-Amino-3-o-chlorobenzoyl-5-ethylthiophene |
50508-60-6 |
| 2-(Aminoacetylamino)-3-(o-chlorobenzoyl)-5-ethylthiophene |
50509-09-6 |
| Baricitinib Series |
Baricitinib API |
1187594-09-7 |
Rheumatoidarthritis
(RA) |
| 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)Ethoxy)-Methyl)-7h-pyrrolo[2,3-d]pyrimidine |
941685-27-4 |
| 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
1187595-85-2 |
| 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1029716-44-6 |
| [4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate |
1146629-77-7 |
| 1-Boc-3-(cyanomethylene)azetidine |
1153949-11-1 |
| Apixaban Series |
Apixaban API |
503612-47-3 |
Thromboprophylaxis |
| 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)Phenyl]-5,6-dihydro-1H-pyridin-2-on |
545445-44-1 |
| 3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone |
503615-03-0 |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este |
536759-91-8 |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone |
1267610-26-3 |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)Phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester |
503614-91-3 |
| ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
503615-07-4 |
| Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester |
27143-07-3 |
| Andere |
Nintedanib intermediates |
2653-16-9 |
IPF |
| Ipragliflozin intermediates |
1034305-17-3 |
Typ 2 Diabetes |
| Tadalafil |
171596-29-5 |
Verbesserung der Sexualität |
| Bupropion HCL |
31677-93-7 |
Antidepressant |
Verkaufsleiter